GSK PLC-SPON ADR (GSK)       35.35  +0.32 (+0.91%)

35.35  +0.32 (+0.91%)

US37733W2044 - ADR - After market: 35.35 0 (0%)

Buy % Consensus

Analysts have set a mean price target of 43.25. This target is 22.35% above the current price.
GSK was analyzed by 35 analysts. The buy percentage consensus is at 70. So analysts seem to be have mildly positive about GSK.
In the previous month the buy percentage consensus was at a similar level.
GSK was analyzed by 35 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target

Price Low Median Mean High 35.3532.2840.8843.2566.35 - -8.67% 15.64% 22.35% 87.69%

Up and Down Grades

Date Firm Action Rating
2022-02-11 DZ Bank Downgrade Buy -> Hold
2021-11-05 Barclays Upgrade Underweight -> Equal-Weight
2021-07-29 Barclays Reiterate Underweight
2021-07-08 Berenberg Bank Reiterate Buy
2021-07-07 Liberum Capital Reiterate Reiteration
2021-06-24 Deutsche Bank Upgrade Hold
2021-06-22 Shore Capital Reiterate Hold
2021-06-16 Libertas Partners Reiterate Buy
2021-06-14 Berenberg Bank Reiterate Buy
2021-06-11 Deutsche Bank Reiterate Sell
2021-05-19 Deutsche Bank Reiterate Sell
2021-05-10 Berenberg Bank Reiterate Buy
2021-04-21 Shore Capital Reiterate Hold
2021-04-16 Berenberg Bank Reiterate Buy
2021-04-15 Liberum Capital Reiterate Buy
2021-04-15 Citigroup Reiterate Neutral
2021-04-12 JP Morgan Cazenove Reiterate Neutral
2021-03-04 Deutsche Bank Reiterate Sell
2021-02-10 Berenberg Bank Reiterate Buy
2021-02-10 Deutsche Bank Reiterate Sell
2021-02-09 JP Morgan Cazenove Reiterate Neutral

Analyst Ratings Stock Screener Links

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA